These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24562790)

  • 1. Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.
    Montico F; Kido LA; Hetzl AC; Lorencini RM; Cândido EM; Cagnon VH
    Histochem Cell Biol; 2014 Sep; 142(3):269-84. PubMed ID: 24562790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Montico F; Kido LA; Hetzl AC; Cagnon VH
    Prostate; 2015 Apr; 75(5):484-99. PubMed ID: 25521760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive stroma in the prostate during late life: The role of microvasculature and antiangiogenic therapy influences.
    Montico F; Kido LA; San Martin R; Rowley DR; Cagnon VH
    Prostate; 2015 Oct; 75(14):1643-61. PubMed ID: 26184673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic and finasteride therapies: responses of the prostate microenvironment in elderly mice.
    Kido LA; Hetzl AC; Cândido EM; Montico F; Lorencini RM; Cagnon VH
    Life Sci; 2014 Jun; 106(1-2):58-70. PubMed ID: 24792519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic and tissue remodeling factors in the prostate of elderly rats submitted to hormonal replacement.
    Montico F; Hetzl AC; Cândido EM; Cagnon VH
    Anat Rec (Hoboken); 2013 Nov; 296(11):1758-67. PubMed ID: 24106075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphology and MMP-9, AR and IGFR-1 responses of the seminal vesicle in TRAMP mice model.
    Dal Pozzo CF; Kido LA; Montico F; Gonçalves MP; Cagnon VH
    Tissue Cell; 2016 Jun; 48(3):217-23. PubMed ID: 27036326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice.
    Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F
    Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic therapy with Nintedanib affects hypoxia, angiogenesis and apoptosis in the ventral prostate of TRAMP animals.
    da Silva RF; Banzato TP; Alves LF; Carvalho JE; Agarwal R; Cagnon VHA
    Cell Tissue Res; 2020 Feb; 379(2):407-420. PubMed ID: 31473819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory therapies in TRAMP mice: delay in PCa progression.
    Kido LA; Montico F; Sauce R; Macedo AB; Minatel E; Costa DB; Carvalho JE; Pilli RA; Cagnon VH
    Endocr Relat Cancer; 2016 Apr; 23(4):235-50. PubMed ID: 26772819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapy in the senescence: Prostatic microenvironment structure and adhesion molecules.
    Montico F; Hetzl AC; Cândido EM; Fávaro WJ; Cagnon VH
    Micron; 2011 Aug; 42(6):642-55. PubMed ID: 21489806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone receptors, matrix metalloproteinases, insulin-like growth factor, and dystroglycans interactions in prostatic diseases in the elderly men.
    Hetzl AC; Fávaro WJ; Billis A; Ferreira U; Cagnon VH
    Microsc Res Tech; 2012 Sep; 75(9):1197-205. PubMed ID: 22648746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
    J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis.
    Huss WJ; Barrios RJ; Greenberg NM
    Mol Cancer Ther; 2003 Jul; 2(7):611-6. PubMed ID: 12883033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined hormonal and insulin therapy on the steroid hormone receptors and growth factors signalling in diabetic mice prostate.
    Fávaro WJ; Cagnon VH
    Int J Exp Pathol; 2010 Dec; 91(6):537-45. PubMed ID: 21039986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
    Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
    Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
    Sroka IC; McDaniel K; Nagle RB; Bowden GT
    Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
    Isayeva T; Chanda D; Kallman L; Eltoum IE; Ponnazhagan S
    Cancer Res; 2007 Jun; 67(12):5789-97. PubMed ID: 17575146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.